---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264969270.md"
description: "Novo Nordisk AS stated that, in light of its commitment to financial discipline and shareholder value, the company will not increase its acquisition offer for Metsera"
datetime: "2025-11-08T08:29:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264969270.md)
  - [en](https://longbridge.com/en/news/264969270.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264969270.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/264969270.md) | [繁體中文](https://longbridge.com/zh-HK/news/264969270.md)


# 

Novo Nordisk AS stated that, in light of its commitment to financial discipline and shareholder value, the company will not increase its acquisition offer for Metsera

### Related Stocks

- [Metsera, Inc. (MTSR.US)](https://longbridge.com/en/quote/MTSR.US.md)
- [Novo Nordisk A/S (NVO.US)](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

- [Novo Nordisk A/S Approves Board Changes](https://longbridge.com/en/news/280694583.md)
- [BREAKINGVIEWS-Novo Nordisk is Denmark’s big little problem: podcast](https://longbridge.com/en/news/280570178.md)
- [Novo Nordisk slashes Wegovy prices to court uninsured patients](https://longbridge.com/en/news/281206892.md)
- [Novo Nordisk Updates Articles of Association and Capital Increase Mandate](https://longbridge.com/en/news/280807928.md)
- [Novo Nordisk A/S Approves Final Dividend for 2025, Payable in March 2026](https://longbridge.com/en/news/280694679.md)